Cheryl W. Grise - 14 Dec 2022 Form 4 Insider Report for METLIFE INC (MET)

Role
Director
Signature
/s/ Anthony Lukaszewski, Authorized Signer
Issuer symbol
MET
Transactions as of
14 Dec 2022
Net transactions value
+$35,619
Form type
4
Filing time
16 Dec 2022, 15:24:25 UTC
Previous filing
05 Oct 2022
Next filing
03 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MET Common Stock Award $35,619 +489 +0.64% $72.84 76,499 14 Dec 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife Inc. common stock that have become payable, but receipt of which the director has deferred.